Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06643611Not ApplicableCompleted

Addressing Disparities in Diabetes Care

Role: collaborator

NCT06263829Not ApplicableRecruiting

HCV Tappt Adherence Study

Role: collaborator

NCT05460390Not ApplicableTerminated

Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis

Role: collaborator

NCT02372539Withdrawn

Glucose Variability in Cancer Patients Receiving Dexamethasone

Role: collaborator

NCT01270594Phase 2Completed

A Pilot Study to Evaluate a Telepharmacy Intervention to Improve Inhaler Adherence in Veterans With COPD

Role: collaborator

NCT00393419Not ApplicableCompleted

Federal Study of Adherence to Medications in the Elderly (FAME)

Role: collaborator

All 6 trials loaded